Prescription medicine
Sinecatechins Brand names: Veregen
Sinecatechins (Veregen) is a prescription medicine with an FDA approval on record since 2006. No generic is listed; pharmacies paid $50.96 per gram (Veregen 15% ointment) in the October 7, 2026 NADAC survey.
- No generic listed
Check it at the source: the sinecatechins FDA label on DailyMed (effective November 10, 2022, ANI Pharmaceuticals, Inc.); the NDA 21902 record on Drugs@FDA; every sinecatechins label on DailyMed.
Highlights of the record
FDA label of November 10, 2022; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usageVeregen is a topical ointment indicated for the treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older (1.1).
Forms and strengths
- 150 mg/g
Ointment.
On the market
- Earliest approval on file
- October 31, 2006 Veregen, Ani Pharms; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
- Last listed patent
- October 2, 2026 Veregen ointment; not a generic launch date
Supply and safety
- Pharmacy cost (NADAC)
- $50.96 per gram Veregen 15% ointment
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 54 through July 30, 2026
What is sinecatechins used for?
From the label: indications and usageVeregen is a topical ointment indicated for the treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older (1.1). […]
Source: FDA drug label (Veregen), NDA021902 (Ani Pharms), as published by ANI Pharmaceuticals, Inc., effective November 10, 2022 (SPL set f0fc1e21-e3cf-4bce-860c-307f670b192e), via openFDA; the full label on DailyMed
What does the patient leaflet for sinecatechins say first?
The FDA-approved Medication Guide or Patient Information that comes with the medicine, in its own words.
From the patient leaflet: What should I avoid while using Veregen Ointment?Do not apply Veregen Ointment on open wounds or into the vagina or into the anus. • Genital warts are a sexually transmitted disease, and you may infect your partner. • Avoid sexual contact (genital, anal or oral) when Veregen Ointment is on your genital or perianal skin. If you do choose to have sexual contact, you must wash off the ointment carefully before having protected sexual contact as the ointment may weaken condoms and vaginal diaphragms. Talk to your doctor about safe sex practices. • Avoid contact with your eyes, nostrils and mouth while ointment is on your finger(s). • Women using tampons: insert the tampon before applying the ointment. If you need to change your tampon while the ointment is on your skin, avoid getting the ointment into the vagina. • Uncircumcised men treating warts under the foreskin should retract the foreskin and clean the area daily. […]
From the patient leaflet: How should I store Veregen Ointment?Store Veregen Ointment refrigerated or up to 77°F (25°C). • Do not freeze. • Make sure the cap on the tube is tightly closed. • Safely throw away Veregen Ointment tubes that are out of date or are empty. Keep Veregen Ointment and all medicines out of the reach of children. General advice about prescription medicines Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use Veregen Ointment for a condition for which it was not prescribed. Do not give Veregen Ointment to other people, even if they have the same symptoms you have. It may harm them. Do not use Veregen Ointment after the expiration date on the tube. This leaflet summarizes the most important information about Veregen Ointment. If you would like more information, talk with your doctor. […]
Source: FDA drug label (Veregen), NDA021902 (Ani Pharms), as published by ANI Pharmaceuticals, Inc., effective November 10, 2022 (SPL set f0fc1e21-e3cf-4bce-860c-307f670b192e), via openFDA; the full label on DailyMed
Is there a generic for sinecatechins (Veregen)?
No generic sinecatechins is approved (Drugs@FDA, October 8, 2026).
The Orange Book lists 1 patent for Veregen ointment, the last expiring on October 2, 2026. A patent or exclusivity date is not the date a generic goes on sale: court cases and settlements move it either way.
- 2006 earliest approval on file
- 2026 last listed patent
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for sinecatechins (Veregen)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $50.96 per gram (Veregen 15% ointment), down 1% from $51.51 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Veregen 15% ointment (brand)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Veregen 15% ointment | Brand | $50.96 per gram | n/a | -1% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What do FAERS reports show for sinecatechins?
The FDA Adverse Event Reporting System holds 54 reports that list sinecatechins among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 0 are coded as a death and 13 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Sinecatechins side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other